Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 421 for “"LDL-C"”.
-
Development of liposomal formulation containing phytosterols and tocopherols with the aim of reducing low density lipoprotein cholesterol (LDL-C)
… can reduce low-density lipoprotein cholesterol (LDL-C) in serum from the range of 8-14% and have been approved by FDA and Health Canada for their cholesterol-lowering abilities. They can be obtained from vegetable oilseeds and their deodorizer distillates. Canola oil deodorizer distillate (CODD) …
-
The association of LDLR and PCSK9 variants with LDL-c levels in a black South African population in epidemiological transition
… of low-density lipoprotein cholesterol (LDL-c) are a major risk factor for the development of coronary artery disease (CAD) because of their role in the progression of atherosclerosis. The black South African population is known to have had historically low LDL-c and in the past there was …
-
Retrospective evaluation of statin therapy medication-taking behaviors and achievement of low density lipoprotein goals by coronary heart disease risk
… identified low density lipoprotein cholesterol (LDL-C) as the largest modifiable risk factor leading to CHD. A variety of drug and non-drug treatments are available for hyperlipidemia, and HMG CoA Reductase Inhibitors or "statins" are the most potent and most widely used agents to lower LDL-C. …
-
Effektivität und Verträglichkeit einer PCSK9-Antikörpertherapie bei Patient*innen mit sehr hohem kardiovaskulärem Risiko. Eine Real-World-Studie
… elevated low density lipoprotein cholesterol (LDL C) are causal for the development and progression of atherosclerotic cardiovascular diseases. For cardiovascular risk reduction, clinical guidelines recommend risk adjusted target values for LDL C reduction. Proprotein convertase …
-
Διερεύνηση του προγνωστικού αποτελέσματος της ρύθμισης των επιπέδων αρτηριακής πίεσης και LDL-χοληστερόλης σε υπερτασικούς ασθενείς. Μία προοπτική μελέτη.
… καρδιαγγειακού κινδύνου. Η μείωση της ΑΠ και της LDL-χοληστερόλης (LDL-C) και η στόχευση σε επίπεδα κατώτερα των ενδεδειγμένων οδηγιών προλαμβάνει τα καρδιαγγειακά επεισόδια και βελτιώνει την πρόγνωση. Σκοπός της παρούσας εργασίας ήταν η διερεύνηση της επίδρασης της συνδυασμένης επίτευξης των …
-
Patient factors affecting prescribing and outcomes in cardiovascular disease
… worldwide. Low density lipoprotein cholesterol (LDL-C) and high blood pressure (BP) are significant risk factors for developing CVDs. Evidence demonstrates a reduction in LDL-C levels and optimal BP control can significantly reduce the incidence of major adverse CV events. However, controlling …
-
Major blood lipids and risk of ischaemic stroke and intracerebral haemorrhage in Chinese adults
… including low-density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), and triglycerides with stroke pathological types. Moreover, the causal relevance of many of these associations is still not fully understood. </p> <p><b>Methods</b> The China Kadoorie Biobank …
-
Lipid Metabolism in Mild to Moderate Multiple Sclerosis
… of PCSK9 and its potential correlation between LDL-C. Methods: A case-controlled design was used to access potential differences in plasma lipids and PCSK9 concentrations in individuals with mild to moderate MS compared with healthy controls. Data was analyzed with a one-way Univariate ANOVA and …
-
Cardiovascular prevention through improved blood pressure and cholesterol lowering
… (BP) and low-density lipoprotein cholesterol (LDL-C) are two major modifiable risk factors. This thesis explores strategies to improve cardiovascular prevention through BP and LDL-C lowering. First this thesis highlights discrepancies between guideline recommendations for BP and LDL-C lowering, …
-
Trans-ethnic associations of plasma lipid traits and blood pressure and risk of myocardial infarction
… levels of low-density lipoprotein cholesterol (LDL-C) and systolic blood pressure (SBP) are among the most important modifiable risk factors for MI. However, uncertainties remain about the strength and shape of their associations with risk of MI across diverse ancestry populations with different …
-
Genetic Contribution of Variants near SORT1 and APOE on LDL Cholesterol Independent of Obesity in Children
… with total (TC), low density lipoprotein (LDL-C), high density lipoprotein (HDL-C) cholesterol and triglyceride (TG) levels in 594 children. Furthermore, we evaluated the expression profile of the candidate genes during human adipocyte differentiation. Results Expression of selected genes …
-
Clinical and molecular genetic characterization of patients with familial hypercholesterolemia
… von Low-Density-Lipoprotein-Cholesterin (LDL-C) und ein deutlich erhöhtes Risiko für die Entwicklung einer Herz-Kreislauf-Erkrankung (CVD) gekennzeichnet ist. Mutationen in drei Hauptgenen wurden mit FH in Verbindung gebracht: das LDL-Rezeptor Gen (LDLR), das Apolipoprotein-B Gen (APOB) …
-
Πρόσθετοι δείκτες αθηρωμάτωσης σε παιδιά με δυσλιπιδαιμία
Aim: To evaluate the importance of small, dense LDL-C (sdLDL-C), urotensin II (U-II) andtotal antibodies against oxidized LDL-C (ox-LDL-Abs) in children with dyslipidemia.Methods: The study population consisted of 648 children (325 males), 4-18 years old, 316with LDL-C ≥130mg/dl and 332 with LDL-C …
-
Weekly One-Day Water-Only Fasting Interventional Trial for Low-Density Lipoprotein Cholesterol Reduction (WONDERFUL)
… influence cardiovascular disease (CVD), like LDL cholesterol. Therefore, the purpose of this study was to assess the effects of weekly water-only fasting on LDL cholesterol (LDL-C) in men and women with metabolic risk factors for CVD. Methods: This study was a randomized control trial in adult …
-
Genetically-predicted effects of LDL cholesterol lowering therapeutic targets on the risk of diabetes
… Statins, which lower circulating LDL-C by inhibiting HMG CoA reductase, are a first-line treatment for prevention of cardiovascular disease. Recent clinical and genetic studies have shown that statins modestly increase the risk of incident type 2 diabetes (T2DM). The biological …
-
Sortilin: A Protein Involved in Ldl Metabolism and Atherosclerosis
… with low-density lipoprotein cholesterol (LDL-C) and is also one of the strongest loci associated with CHD. Homozygosity for the minor allele haplotype at 1p13 is associated with a >10 fold increase in hepatic SORT1 expression, a mean 16 mg/dL reduction in plasma LDL-C, and a 40% reduction …
-
Μελέτη δεικτών αθηρωμάτωσης σε υγιή παιδιά και εφήβους της Αττικής
… fasting plasma, in some of the study population. LDL-C levels were directly measured by a homogeneous method and calculated using the Friedewald and Anandaraja formulas. The risk of atherosclerosis was estimated based on the high levels of LDL-C and non-HDL-C. The levels of directly measured LDL-C …
-
Improving diagnosis and care of familial hypercholesterolemia : from genetic testing to outcomes
… elevated low-density lipoprotein cholesterol (LDL-C) from birth and increased risk of premature atherosclerotic cardiovascular disease (ASCVD). FH is typically caused by pathogenic variants in LDLR, APOB, and PCSK9. Despite effective lipid-lowering therapies, FH remains underdiagnosed and …
-
A Vegan Diet Compared to a Mediterranean Diet on Plasma/Serum Cholesterol Concentrations in Hypercholesterolemic Adults
… (TC), low-density lipoprotein-cholesterol (LDL-C), and non-high-density lipoprotein-cholesterol (non-HDL-C). According to the Academy of Nutrition and Dietetics (AND), vegan diets have proven to be the most effective diets for improvement of heart disease risk factors. On the other hand, the …
Page 1 of 22